Llwytho...
Outcome measures for clinical trials assessing treatment of cystic fibrosis lung disease
Cystic fibrosis (CF) is a complex genetic disease characterized by death from loss of lung function. Therapies target pathophysiologic changes associated with pulmonary disease progression. Although therapeutic mechanisms differ, efficacy demonstration is limited to a few accepted outcome measures,...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Clin Investig (Lond) |
|---|---|
| Prif Awduron: | , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
2012
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4486293/ https://ncbi.nlm.nih.gov/pubmed/26146539 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4155/cli.11.174 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|